SCIENTIFIC PUBLICATIONS
A. BOOKS AND MONOGRAPHS
1. Charach G, Argov O, Rogowski O, Grosskopf I.
Impact of Anti-Oxidized Low- Density Lipoprotein Antibodies in Heart Failure and Coronary Artery Disease. Role of Antioxidants.
Med Crave 2016,1-24. Monograph.
B.1. ORIGINAL ARTICLES*
B.1. Articles Published
1. Groskopf I, Graf E, Charach G, Binymin G, Spinrad S, Blum I. Hyperphosphatemia and hypocalcemia induce by hypertonic phospate enema-an experimental study and review of the literature.
Human and Experimental Toxicology 10: 351-355, 1991 IF-1.45
2. Rubin M, Halperin Z, Charach G, Dvir A, Entebi E, Gilat T, Lichtenberg D.
Effect of lipid infusion on bile composition and litogenicity in patients without cholesterol gall stones.
Gut 33: 1403-1403, 1992. IF-9.825
3. Rattan J, Gay F, Charach G, Arber N, Groskopf I.
Il trattemento endoscopico delle stenosi esophagee.
Chirurgia Generale-General Surgery 14: 293-297, 1993 : .
4. Halpern Z, Grotto J, Charach G, Moser A, Dvir A, Lichtenberg D, Gilat T.
Bile and plasma lipid composition in non obese normolipidemic subjects with and without cholesterol gallstones.
Liver13: 246-252, 1993. IF-2.9
5. Zahavi J, Charach G, Shafer R, Toeg A.
Ischemic necrotic toes associated with Antiphospholipid Syndrome and treated with Iloprost.
Lancet 342: 862-863, 1993. IF-33.633
6. Rubinstein A, Groskopf I, Charach G, Levtov O, Geter R, Villa J, Golbourt U.
Lipids and lipoproteins among Ethiopeans immigrants comparison of Operations Solomon and Moses.
Isr. J. Med.Sci.29: 353-359, 1993 IF-0.953
7. Groskopf I, Ben David A, Charach G, Hochman I,Binyamin G, Pitlik S.
Bone and joint tuberculosis -a ten year review.
Isr. J.Med. Sci. 30: 278-282, 1994. IF-0.953
8. Weintraub M, Rasin T, Eisenberg S, Ringel J, Groskopf I, Iaina A, Charach G, Liron M, Rubinstein A.
Continuous intravenous heparin administration in humans causes a decrease in serum lipolitic activity and accumulation of chylomicrones in the circulation.
J.Lip.Res. 35: 229-238, 1994. IF-6.115
9. Weintraub M, Groskopf I, Charach G, Mor R, Rubinstein A, Wollman Y, Judevich R, Iaina A.
Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosis.
Metabolism 44: 1401-1409, 1995. IF-2.9
10. Weintraub M, Groskopf I, Rassin T, Miller H, Charach G, Rotmensh H, Liron M, Rubinstein A, Iaina A.
Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease:case control study over three years.
BMJ,312: 935-939,1996. IF-12.8
11. Vered Y, Groskopf I, Palevich D, Harsat A, Charach G, Weintraub M, Graf E.
The influence of Vitia Faba(Broad Bean) Seedlingson urinary sodium excretion.
Planta Medica 93: 195-290, 1997. IF-2.369
12. Groskopf I, Ringel Y, Charach G, Maharshak N, Mor R, Iaina M, Weintraub M.
Metformin Enhances Clearence of Chylomicrons and Chylomicrone Remnant in Nondiabetic Subjects with Mild Overweight and Glucose Intolerance.
Diabetes care 20:1598-1602,1997. IF-7.141
13. Weintraub M, Charach G, Grosskopf I.
Disturbances in Dietary Fat Metabolism and their Role in Development of Atherosclerosis.
Biomed. + Pharmacother, 51 : 314-317, 1997. IF-4.086
14. Charach G, Rabinovich P, Konikof F, Groskopf I, Weintraub M, Gilat T.
Decreased fecal bile output in patients with coronary heart disease.
J. Med. 29:125-136,1998 IF-0.953
15. Weintraub M, Charach G, Groskopf I.
Effects of fibric acid derivates and metformin on postprandial lipemia.
Atherosclerosis 141 Suppl.1 (1998 ), S71-S75 IF-4.086
16. Weintraub M, Groskoph G, Charach G.
Variations in lipid and lipoprotein levels in women taking HRT.
Cardiology Review 16: 38-42, 1999 No-IF
17. Weintraub M, Groskoph I, Charach G, Eckstein N, Rubinstein A.
Hormone Replacement Therapy Enhances Postprandial Lipid Metabolism in Postmenopausal Women.
Metabolism 48: 1193-1196, 1999.: 1193-1196, 1999. IF- 2. 9
18. Weintraub M, Groskoph I, Trostanesky Y, Charach G, Rubinstein A, and Stern N.
Thyroxine Replacement Therapy Enhances Clearence of Chylomicrone remnants in Patients with Hypothyroidism.
Endocrinol Metab 84: 2532-2536,1999. IF-6.3
19. Charach G, Grosskopf I, Weintraub.
Variations in lipid and lipoprotein levels in women taking HRT.
Cardiology Review 1999;16(7) 38-42. IF 2.862
20. Weintraub M, Groskoph I, Charach G, Ringel Y, Eckstein H, Rotmensh H, Rubinstein A.
Fluctuations in plasma lipids and lipoproteins of hyperlipidemic postmenopausal women on combined hormone replacement therapy.
Arch. Int. Med. 158:1803-1806,1998. IF-10.639
21. Charach G, Grosskopf I, Greenstein A, Rabinovch P, Weintraub M.
Alleviation of constipation improves lower urinary tract symptoms in elderly. Gerontology 47(2): 72-76,2001. IF-2.203
22. Charach G, Rabinovich P, Weintraub M, Grosskopf I.
Transthoracic monitoring of the impedance of the right lung in patients with cardiogenic pulmonary edema.
Critical Care Med. 29:1137-1144, 2001 IF-6.59
23. Charach G, Rabinovich P, Weintraub M.
Seasonal changes in blood pressure and frequency of related complications in elderly Israeli patients.
Gerontology 2004;50 :315-321. IF-4.252
24. Charach G, Groskopf I, Rotmensch H, Kitzis I, and Weintraub M.
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal disease.
Nephron Clin Practice 2005;100(4):c120-125 IF-1.843
25. Shochat M, Charach G, Myeler S, Kazatzker M, Mosseri M, Friemerman A, Rabinovich P, Shotan A, Meisel S.
Internal thoracic impedance monitoring: anovel method for the preclinical detection of acute heart failure.
Cardiovasc Revasc Med 2006 7(1): 41-5. IF 3.39
26. Shochat M, Charach G, Myeler S, Meisel S, Weintraub M, Mengeritsky G, Mosseri M, Rabinovich P.
Prediction of cardiogenic pulmonary edema by monitoring right lung impedance.
Intesive Care Med 2006; 32(8): 1214-21. IF 4.996
27. Charach G, Kaysar N, Grosskopf I, and Weintraub M.
Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data.
J Clin Pharmacol. 2009 Jul;49(7):848-51 IF 3.59
28. Charach G, Rabinovich P, Weintraub M.
Streamlining differential diagnosis of coronary heart disease in a primary care clinic: atypical and typical symptoms and their combinations.
The Open General and Internal Medicine Journal, 2009, 3, 47-52 IF-2.83
29. Charach G, George J, Afek A, Wexler D, Sheps D, Keren G, Rubinstein A.
Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure.
J.Card Fail. 2009,15(9):770-4. IF 3.362
30. Charach G, George J, Afek A, Wexler D, Sheps D, Keren G, Rubinstein A.
Baseline Low-density Lipoprotein Cholesterol Levels and Outcome in Patients with Heart Failure.
Am J Cardiol. 2010,105(1):100-4 IF 3. 681
31. Schwartzenberg S, Afek A, Charach G, Rubinstein A, Ben-Shoshan Y, Kissil S, Maisel-Auslender S, Keren G, George J.
Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome.
World J Cardiol, 2010;2(9):299-304. IF-2.092
32. Charach G, Grosskopf G, Rabinovich A, Weintraub M, Rabinovich P.
The association of bile acid excretion and atherosclerotic coronary artery disease.
Ther Adv Gastroenterol 2011; 4(2) 95-101 IF-2.092
33. Charach G, Roth A, MD, Wexler D, Sheps D, Keren G, George G.
Usefulness of Total Lymphocyte Count as Predictor of Outcome in Patients with Chronic Heart Failure.
Am. J. Cardiol. 2011 May 1; 107(9):1353-6 IF-3.681
34. George J, Schwartzenberg S, Medvedovsky D, Jonas M, Charach G, Afek A, Shamiss A.
Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques.
Atherosclerosis 2012; 222(2):519-23 IF-4.6
35. Charach G, Shochat M, Rabinovich A, Ayzenberg O, George J, Charach L, Rabinovich P.
Preventive treatment of alveolar pulmonary edema of cardiogenic origin.
JGC Journal of Geriatric Cardiology 2012; 9: 321−327
Cardiac and cardiovascular system IF-2.203, 5year IF-1.892 64/136,Q2;Cited 3
36. Charach G*, Argov, Weksler D, Sheps D, Charach L, Weintraub M, George J.
Low LDL Cholesterol: a Negative Predictor of Survival in Elderly Patients with Advanced Heart Failure.
Cardiology 2014;127:45–50 IF 1.519 70/122
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
37. Charach G, Rubalsky O, Charach L, Rabinovich A, Argov O, Rogowski O, George J.
Internal thoracic impedance - a useful method for expedient detection and convenient monitoring of pleural effusion.
PLoS ONE. 2014;10(4):e0122576.
IF 2.776; MULTIDISCIPLINARY SCIENCES 24/69 – Q2; Cited: 1.
38. Rotman-Pikielny P, Ness-Abramof R, Charach G, Roitman A, Zissin R, Levy Y.
Efficacy and safety of the dietary supplement DBCare® in patients with type 2 diabetes mellitus and inadequate glycemic control.
J Am Coll Nutr. 2014;33(1):55-62.
IF 2.08; NUTRITION & DIETETICS 59/87 – Q3; Cited: 3.
39. Charach G, Michowitz Y, Rogowski O, Charach L, Argov O, George J, Grosskopf I.
Usefulness of Antibodies to Oxidized Low-Density Lipoproteins as Predictors of Morbidity and Prognosis in Heart Failure Patients Aged ≥65 Years.
Am J Cardiol. 2015;116(9):1379-84.
IF 2.843; CARDIAC & CARDIOVASCULAR SYSTEMS 59/136 – Q2; Cited: 3.
40. Grosskopf I, Shaish A, Charach G, Harats D, Kamari Y.
Nifedipine Treatment for Hypertension is Associated with Enhanced Lipolytic Activity and Accelerated Clearance of Postprandial Lipemia.
Horm Metab Res. 2016;48(4):257-62.
IF 2.423; ENDOCRINOLOGY & METABOLISM 97/145- Q3; Cited: 1.
41. Charach G, Argov O, Geiger K, Charach L, Rogowski O, Grosskopf I.
Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome.
Therap Adv Gastroenterol. 2018;11:1756283X17743420.
IF 3.961; GASTROENTEROLOGY & HEPATOLOGY 25/84 – Q2; Cited: 7.
42. Charach G, Argov O, Nochomovitz H, Rogowski O, Charach L, Grosskopf I.
A longitudinal 20 years of follow up showed a decrease in the survival of heart failure patients who maintained low LDL cholesterol levels.
QJM. 2018;111(5):319-25.
IF 2.649; MEDICINE, GENERAL & INTERNAL 42/160 – Q2; Cited: 1.
43. Kheifets M, Karniel E, Landa D, Vons SA, Meridor K, Charach G.
Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
Isr Med Assoc J. 2019;21(6):404-7.
IF 0.828; MEDICINE, GENERAL & INTERNAL 125/160 – Q4; Cited: 0.
44. Charach G, Rogowski O, Karniel E, Charach L, Grosskopf I, Novikov I.
Monocytes may be favorable biomarker and predictor of long-term outcome in patients with chronic heart failure: A cohort study.
Medicine (Baltimore). 2019;98(38):e17108.
IF 1.87; MEDICINE, GENERAL & INTERNAL 69/160 – Q2; Cited: 0.
45. Charach G, Karniel E, Novikov I, Galin L, Vons S, Grosskopf I, Charach L.
Reduced bile acid excretion is an independent risk factor for stroke and mortality: A prospective follow-up study.
Atherosclerosis. 2020;293:79-85.
IF 3.919; PERIPHERAL VASCULAR DISEASE 16/65 – Q1; Cited: 0.
46. Charach G, Karniel E, Grosskopf I, Charach L.
Monitoring Pleural Effusion in Elderly Patients Using Internal Thoracic Impedance.
Isr Med Assoc J. 2020;22(2):94-9.
IF 0.86; MEDICINE, GENERAL & INTERNAL 129/165 – Q4; Cited: 0.
47. Charach G, Karniel E, Grosskopf I, Rabinovich A, Charach L.
Methylphenidate has Mild Hyperglycemic and Hypokalemia Effects and Increases Leukocyte and Neutrophil Counts.
Medicine (Baltimore). 2020;99(27):e20931.
IF 1.552; MEDICINE, GENERAL & INTERNAL 89/165 – Q2; Cited: 0.
48. Charach G, Grosskof I, Galin L, Robinson E, Hershenson R, Charach L.
Usefulness of cardiac biomarkers for prognosis of better outcome in chronic heart failure: retrospective 18 year follow- up study".
Medicine (Baltimore). 2021; 100(5): e23464
IF 1.889; MEDICINE, GENERAL & INTERNAL 89/165 – Q2; Cited: 0.
49 Charach L, Blatt A, Theodorovitz N,Haberman D, Gendelman G, Grosskopf I,
George J, Charach G.
Using the Gensini Score to Estimate Severity of STEMI, NSTEMI, Unstable
Angina and Anginal Syndrome" Medicine 2021;100:41 (e27331).
IF 1.889; MEDICINE, GENERAL & INTERNAL 89/165 – Q2; Cited: 0.
50. Charach L, Grosskopf I*,Karniel E, Charach G.
A Meteorological Paradox: Low Atmospheric Pressure-Associated Decrease in Blood Pressure is Accompanied by More Cardiac and Cerebrovascular Complications: Five-year Follow-up of Elderly Hypertensive Patients Atmosphere 2022,13,235:1-9
LEAD AUTHOR SUMMERY
Article Info Current Data (year) Original Data (year)
No. Journal IF Rank Quartile IF Rank Quartile
37 PLoS ONE. 2.776 24/69 Q2 3.234 24/69 Q1
39 Am J Cardiol. 2.843 59/136 Q2 3.154 43/124 Q2
41 Therap Adv Gastroenterol. 3.52 40/88 Q2 3.961 25/84 Q2
42 QJM. 2.529 49/165 Q2 2.649 42/160 Q2
43 Isr Med Assoc J. 0.86 129/165 Q4 0.828 125/160 Q4
44 Medicine (Baltimore). 1.552 89/165 Q3 1.87 69/160 Q2
45 Atherosclerosis. 3.919 16/65 Q1 3.919 16/65 Q1
46 Isr Med Assoc J. 0.86 129/165 Q4 0.86 129/165 Q4
47 Medicine (Baltimore). 1.552 89/165 Q3 1.552 89/165 Q3
48 Medicine (Baltimore). 1.552 89/165 Q3 1.552 89/165 Q3
B.1. Articles Accepted
1. Gideon Charach, Lior Charach, Eli Karniel, Dorin Bar Ziv, Leonid Galin, Weintraub M, Itamar Grosskop
Apolipoprotein E (APOE) Genotypes in the Israeli population
IMAJ2022 IF 0.86; MEDICINE, GENERAL & INTERNAL
B.1. Articles Submitted
Lior Charach MD1, Itamar Grosskopf 1, Eli Karniel MD1, Leonid Galin MD1, Dorin Bar Ziv1, Lior Grossman1, Irit Kaye1 MD, Gideon Charach MD1
PLOS ONE
Peripheral vascular disease and carotid artery disease correlates with bile acid excretion
1 Rady Qasem A, Robinson E, Charach G.
Severe Fibrosis and Multiple Pneumatocele Development in COVID 19.
Lancet 2021.
B.2. CASE REPORTS
B.2. Case Reports published
1. Charach G, Sztern M, Josipov J, Blum I.
Diabetes insipidus as a presenting sign of metastatic clear cell carcinoma. Isr.J. Med. Sci.26: 580-582, 1990. IF-0.978
2. Charach G, Groskopf I, Kugel Ch, Weintraub M.
Syphilitic gumma and tuberculosis. Unusual combination in AIDS.
IMAJ 2002; 4: 463-464. IF-0.078
3. Rotmensch H, Kitzis I, Charach G, Weintraub M.
Reversible mental and behavioral disturbances due to giant mediastinal parathyroid Adenoma induced hypercalcemia.
IMAJ 2002; 4: 1154-1155. IF-0. 18
4. Charach G, Marmur M, Ben Soussan S, Weintraub M.
Giant Femoral Abscess due to suprapatellar pouch perforation.
IMAJ 2006;8(7):517 IF-0.978
5. Argov O, Weintraub M, Charach G.
Doughnut granulomas from erythema nodosum in acute Q fever.
IMAJ 2008 Mar;10(3):241-2. IF-0.018
6. Charach G, Groskopf I, Weintraub M.
Development of Crohn's disease in patient with multiple sclerosis treated by Copaxone.
Digestion 2008;77:198-200. IF-1.7
7. Argov O, Charach G, Weintraub M, Stabsky A.
Angioimmunoblastic Tcell lymphoma presenting as giant kidneys:a case report. Journal of medical case reports 2009,3:9258. No IF
8. Charach G.
Femoral Abscess due to Suprapatellar Pouch Perforation (Case Report Electronic Journal).
SurgyTec 2009, June 5. No IF
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
9. Argov O, Weintraub M, Charach G.
Multiple-shower thromboembolism in an artificial mitral valve patient.
BMC Res Notes. 2013;6:4.
10. Charach G, Grosskopf I, Shteinvil R, Ehrnwald M, Nochomovitz H, Charach L, Zusmanovich L, Rogowski O, Argov O, Charach G, Grosskopf I, Shteinvil R, Ehrnwald M, Nochomovitz H, Charach L, Zusmanovich L, Rogowski O, Argov O.
Unusual Coexistence of Giant Cell Tumor and Small Bone Tuberculosis of the Hand - A Case Report.
Global Journal of Medical and Clinical Case Reports. 2016;3(1):026-8.
11. Hibsher D, Argov O, Zilberstein N, Nochomovitz H, Gal D, Tamam O, Zilberman A , Charach G.
A Unique Case of Brucellosis with Central Nervous System Neurovasculitis.
Adv Neur Neur Sci. 2018;1(1):1-3.
12. Maymon S, Globus O, Friedman I, Nochomovitz H, Steinvil R, Bahir I, Angel Y, Rogowski O, Argov O, Charach G.
Unusual coexistence of cytomegalovirus and Epstein: Barr virus infection in an immunocompetent adult patient.
Int J Acad Res Dev. 2018;3(2):924-6.
13. Zusmanovich L, Charach L, Charach G.
Current Microbiological, Clinical and Therapeutic Aspects of Impetigo.
Clin Med Rev Case Rep 2018; 5(3):205.
B.2. Case Reports Accepted
B.2. Case Reports Submitted
1. Hershenson R*, Tayer-Shifman O*, Karniel E, Robinson E, Rady Qasem A, Eliashiv D, Maor L, Kimchy O, Charach G.
Unusual presentation of Intractable Ascites and Pleural Effusion as a Sole Manifestation of IgG4 Related Disease: A case report.
IMAJ 2020.
B.3. REVIEW ARTICLES
B.3. Review Articles Published
1. Toeg A, Charach G, Shafer R, Zahavi J.
Superantigens and human diseases.
Harefuah 126: 719-728, 1994. No IF
2. Weintraub M, Charach G, Groskopf I.
Diet therapy in Dyslipidemia.
Cardiology Update 11: 12-16, 1995. No IF
3. Charach G, Grosskopf G, Rabinovich A, Argov O, Weintraub M, Rabinovich P.
The role of bile acid excretion in atherosclerotic coronary artery disease.
International Journal of Vascular Medicine,Hindawi Publishing Corporation
Int J Vasc Med. 2012;2012: 949672. Epub 2011 Sep 12. 3pg.
4. Charach G, Rabinovich A, Argov O, Weintraub M, Charach L, George J.
Anti-oxidized Low-density Lipoprotein Antibodies in Chronic Heart Failure.
World J Cardiology 2012 ;4(11):302-8. IF-2.092
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
5. Charach G, Shochat M, Argov O, Weintraub M, Charach L, Rabinovich A, Ayzenberg O, George J.
Seasonal changes in blood pressure: Cardiac and cerebrovascular morbidity and mortality.
World J Hypertens. 2013;3(1):1-8.
6. Charach L, Zusmanovitch L, Charach G.
Hepatocellular Carcinoma Current review.
Hepatocellular Carcinoma. Part 1: Epidemiology, Risk Factors, Pathogenesis and Pathology.
EMJ Hepatol. 2017;5(1):75-80.
7. Charach L, Zusmanovitch L, Charach G..
Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis.
EMJ Hepatol. 2017;5(1):81-8.
8. Charach L, Zusmanovitch L, Charach G.
Hepatocellular Carcinoma. Part 3: Surgical and Medical Treatment.
EMJ Hepatol. 2017;5(1):89-96
9. Zusmanovitch L ,Charach L, Charach G .
Current Microbiological, Clinical and Therapeutic Aspects of Impetigo.
Clin Med Rev Case Rep. 2018;5(2).
10. Zoref-Lorenz A, Slavin-Kish M, Kalisky I , Charach G, Kheifets M.
DRESS syndrome- an unusual presentation with pancytopenia after salazopyrin treatment.
Clin Med Res. 2020;7(3):215-7.
B.3. Review Articles Accepted
B.3. Review Articles Submitted for Publication
C. CHAPTERS IN BOOKS
1. Charach G, Kaysar N, Rabinovich A, Argov O, Weintraub M.
Methylphenidate and Dyslipidemia.
In Norvilitis JM, ed. Current Directions in ADHD and Its Treatment.
InTech (SAGE); 2012: 185-92.
D.1.INVITED PAPERS IN SCIENTIFIC MEETINGS
1. Charach G, Rabinovich P, Shochat M, Milman O.
Detecting Pulmonary Edema at Pre-Clinical Stage and Monitoring its Course. A new method and new algorithm for prolonged monitoring of internal thoracic impedance
The 6th Annual Symposium on Medical Physics and Medical instrumentation Jerusalem College of Technology-Machon Lev. April 8, 1998 Jerusalem Oral presentation
2. Charach G.
Hypocholesterolemic and hypotriglyceridemic effects of Methylphenidate.
BIT’s 2nd Annual World Congress of Immunodiseases and Therapy (WCIT).
November 18-20, 2010 Guangzhou, China. Oral presentation.
3. Charach G.
Antibodies to Ox LDL – reflect oxidative stress in HF patients.
BIT’s 2nd Annual World Congress of Immunodiseases and Therapy (WCIT).
November 18-20, 2010 Guangzhou, China. Oral presentation.
4. Charach G.
Total Lymphocyte Count as Predictor of Outcome in Patients with Chronic HF.
BIT's 3rd Annual International Congress of Cardiology(ICC-2010).
Track 5-16: Coronary Artery Disease Risk Factors. December 4-6, 2010 Beijing, China.
5. Charach G, Argov O.
Bezafibrates cause, reversible impairment in renal function.
Sixth Congress of Nephrology in Internet, CIN2011, November 2011.
Oral Video presentation
6. Charach G.
Methylphenidate impact on lipid profile.
EPS Nanjing International Forum on Pharmaceutical, Nutraceutical and Biotechnology. September 20-22, 2012 in Nanjing, Jiangsu, China. Invited
7. Charach G.
Influence of low-density lipoprotein cholesterol levels and outcome in heart failure Patients.
Annual Scientific Sessions 2012, Vancuver, BC, Canada, July 27-30, 2012.
D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS
1. Charach G, Graph G, Lancet M.
The impact of fetal heart monitoring during labor in women with high risk pregnancy.
7th Scientific Meeting of the Israel Society of Obstetrics and Gynecology. Jerusalem Hilton; May 14 -16, 1980. ORAL PRESENTATION
2. Halpern Z, Rubin M, Charach G, Dvir A, Gilat T.
Infusion of lipid emulsions does not alter the fatty acid distribution in the bile.
Gastroenterology Congress. Gothenburg, Sweden, 22-23 June, 1990.ORAL PRESENTATION
3. Rubinstein A, Charach G, Groskopf I, Weintraub M.
Cholesterol lowering effect of 10mg / day dose of Lovastatin in patients with initial total cholesterol levels of 200 - 240 mg / dl.
11th International Symposium of Drug Affecting Lipid Metabolism. Florence, May 13 -16, 1992. Poster
4. Rubinstein A, Kofler M, Charach G.
Gulf War and diabetes.
Scientific Meeting of the Israel Diabetes Society. Tel - Aviv, Plaza Hotel; November 1992. Oral presentation
5. Charach G, Zahavi J, Shafer R, Zahavi M.
Successful management of ischemic necrotic toes in patients with Antiphospholipid Syndrome(APS) by Iloprost, a stable prostacyclin analogue. An important new modality.
14th Congress of the International Society on Thrombosis and Hemostasis, Sheraton; New York, July 4-9, 1993 Oral presentation
6. Charach G.
Decreased bile acid output in patient with coronary atherosclerosis.
Israeli Society for Research, Prevention and Treatment of Atherosclerosis. Princess Eilat; March 14-17, 1996. Oral presentation.
7. Charach G, Rabinovich P, Konikoff F, Groskopf I, Weintraub M, Gilat T.
Bile acid excretion in patient with coronary atherosclerosis.
Abstract. Israeli Gastroenterological Association Meeting. Ganei Moriah. Zichron Yaacov 6-8 June, 1996. Oral presentation.
8. Groskopf I, Charach G, Ringel Y, Weintraub M.
Clearance of chylomicron remnants in normolipidemic post menopausal women is enhanced by estrogen treatment.
Israeli Society for Research, Prevention and Treatment of Atherosclerosis Annual Meeting, Dan Hotel; Eilat, March 6-8, 1997. Poster.
9. Charach G, Rabinovch P, Groskopf I,Weintraub M.
Low fecal bile acid output in patients with coronary artery disease(CAD).
4th International Symposium on Multiple Risk Factors in Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure and Stroke. Washington Hilton and Towers, Washington D.C. April 23-25, 1997 Poster.
10. Groskopf I, Charach G, Ringel Y, Weintraub M.
Clearance of chylomycrone remnants in normolipidemic postmenopausal women is enhanced by estrogen treatment.
4th International Symposium on Multiple Risk Factors in Cardiovascular Disease: Strategies of Prevention of Coronary Heart Disease, Cardiac Failure, and Stroke. Washington Hilton and Towers, Washington D.C. April 23-25, 1997. Poster
11. Weintraub M, Groskopf I, Charach G.
Significant fluctuations in plasma lipids and lipoproteins of hyperlipidemic postmenopausal women on cobineld hormone replacement therapy.
Montreal June 29-July3, 1997, Convention Center Poster B-0929.
12. Charach G, Rabinovich P.
Monitoring of Acute Pulmonary Edema by Internal Thoracic Impedance.
Montreal, June 29- July 3, 1997.
13. Charach G, Rabinovich P, Konikoff F.
Fecal bile acid excretion in patients with coronary atherosclerosis and in mached controls.
11th International Symposium on Atherosclerosis. Paris 5-9 October 1997 Poster-1.P59.
14. Groskopf I, Weintraub M, Charach G, Raz A.
Apparent Stimulation of Dihomo – Y- linoleic –Acid (DGLA) Conversion to Arachidonic Acid (AA) by Metformin.
13th International Symposium on Drugs Affecting Lipid Metabolism. May 30-June 3, 1998 Florence.
15. Charach G, Shochat M,Rabinovich P I,Weintraub M.
Monitoring of Acute Pulmonary Edema.
6th International Conference on Non Invasive Cardiology. Jerusalem, Israel, December 20-22 1998. Oral Presentation.
16. Charach G, Rabinovich P, Shochat M, Weintraub M.
Monitoring of Acute Pulmonary Edema.
6th International Conference on Non-Invasive Cardiology. Jerusalem, Israel, December 20-22 1998. Oral Presentation.
17. Rabinovich P, Shochat M, Charach G, Milman O.
A new method and new algorithm for prolonged monitoring of internal thoracic impedance.
The 6th Annual Symposium on Medical Physics and Medical Instrumentation. Jerusalem College of Technology-Machon Lev April 8, 1998 Jerusalem Oral presentations.
18. Charach G, Rabinovich P, Weintraub M.
Detecting Pulmonary Edema at Pre-Clinical Stage and Monitoring its Course.
Annual Meeting of Israeli Cardiology Society. April 20-21, Jerusalem 1998. Poster
19. Charach G, Rabinovich P, Shochat M, Weintraub M.
Monitoring of Acute Pulmonary Edema.
International Meeting –Intensive Cardiac Care-International Convention Center-Jerusalem – June 28 – July 3, 1998.
20. Groskopf I, Charach G, Weintraub M.
Chylomicrone Remnants is Dependent on The Ratio of Total to HDL-C in Normolipidemic Individuals with Normal Coronary Arteries.
The European Atherosclerosis Society 71st EAS Congress May 20-26 1999 Athens, Greece. Poster
21. Charach G.
Detecting Pulmonary Edema at Pre-Clinical Stage and Monitoring its Course.
21st Congress of the European Society of Cardiology August 28 - 1 September – 1999 Barcelona-Spain.
22. Charach G, Rabinovich P.
Treatment of constipation improves lower urinary tract symptoms.
Annual Meeting of American Family Physician Society, 12-17 August, 2000.Washington. Poster.
23. Charach G.
Novel treatment approaches of Hypercholesterolemia in diabetics- goals and ways to achieve them.
Family Physicians Meeting .Golden Tulip Hotel, the Dead Sea. 5-7.02.2004. Oral Presentation.
24. Charach G.
Bezafibrates cause moderate, reversible impairment in renal functioning patients without prior renal disease (Oral Presentation-Lecture).
15th International Symposium on Drugs Affecting Lipid Metabolism. Venice, Italy, Venice Convention Center, October 24-27, 2004.
25. Rabinovich P. Charach G.
EHREN-URKUNDE-International "Ausstellung Ideen-Erfindungen-Neuheiten" Nurenberg 2004.
Rostislav Nevler, RSSM Ltd. BASHAN-Technological Implementations Program Israel, Wurde fur hervorragende Leistungen eine. Goldmedaille verliehen Goldmedal for RSSM monitor in the International Exhibition of the Medical Equipment Nuremberg 2004) Poster
26. Groskoph I, Morad T, Charach G, Grynberg E, Perez H.
Apo A-5 affects blood triglyceride-rich-lipoproteins.
Ongoing Scientific and Clinical Investigations Tel-Aviv Sourasky Medical Center, January 10-12, 2005
27. Charach G, Argov O.
Bezafibrates cause, reversible impairment in renal function.
Conference for Independent Doctors, Maccabi Healthcare System. Eilat, 9-21.01.2006. Poster.
28. Charach G, Argov O.
Bezafibrates cause moderate, reversible impairment in renal function in patients without prior renal disease
Asia Pacific Obesity Conclave March 1-5 2006 NEW DELHI INDIA.
29. Charach G, Grosskopf I, Weintraub M.
Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone.
Rare Neuroimmunologic Disorders Symposium. John Hopkins University. Sheraton Inner Harbor Hotel 18-23 July 2006 Baltimore, Maryland, USA Poster
30. Charach G, Michovich Y, Wexler D, Sheps D, Keren G, George J.
Antibodies to Oxidazed LDL as Predictor of Morbidity and in Patients with Chronic Heart Failure.
The 54th Annual Conference of the Israel Heart Society an Israel Society of Cardiac Surgery- Hotel David Intercontinental Tel-Aviv, 18-19 of April 2007 (Oral presentation(.
31. Charach G, Rogowsky O, Weksler D, Sheps D, Keren G, George J.
Baseline LDL- cholesterol Levels and Prognosis in Patients with Severe HF.
The 55th Annual Conference of the Israel Heart Society and Israel Society of Cardiac Surgery- Hotel David Intercontinental, Tel-Aviv, 9-10 of April 2008 (Oral presentation).
32. Charach G, Rogowsky O, Weksler D, Sheps D, Keren G, George J.
Low LDL- Cholesterol Levels and Outcome in Patients with Severe Heart Failure.
The 77th Congress of the European Atherosclerosis Society.
April 26-29 2009, Istanbul, Turkey Oral Presentation
33. Charach G.
Seasonal changes in blood pressure and related complications.
Balneotherapy and Hydrotherapy in Rheumatological Diseases. August 22-28, 2010, Druskininkai, Lithuania. Poster.
34. Charach G.
Dead Sea Resorts and treatment of Psoriasis.
Balneotherapy and Hydrotherapy in Rheumatological Diseases. August 22-28, 2010, Druskininkai, Lithuania. Poster.
35. Charach G.
Crohn's disease in patient with multiple sclerosis treated by Copaxone.
International and Pan-Russian Scientific-Practical Conference in Medical Allergology and Mycology. (Kashkins Lectures).Postgraduate Academy June 22-24 2011 S. Petersburg. Poster.
36. Charach G.
Fibrates treatment may induce kidney injury.
Sixth Congress of Nephrology on the Internet. 2011.
37. Charach G.
Antibiotic Resistance
Second European Conference of Antimicrobial Resistance and Infection Prevention.
Government’s Meeting Hall, Vilnius Lithuania October 4-5, 2012.
38. Charach G.
Seasonal blood pressure changes. Cardiac and Cardiovascular Morbidity
Cin2013-7th Congress of Nephrology on the Internet Oral Video presentation. November 2013.
39. Charach G.
Fibrates treatment cause impairment in renal function.
Cin2013-7th Congress of Nephrology on the Internet Oral Video presentation. November 2013.
40. Charach G.
Statin treatment and Outcome in Patients with Severe Heart Failure.
18th Annual Meeting of the Israeli Society for Research, Prevention and Treatment of Atherosclerosis. Eilat, 2013. December 2013, Royal Beach Poster
41. Charach G.
Oxidized LDL Ab –best predictor for morbidity and combined outcome in HF patients.
18th Annual Meeting of the Israeli Society for Research, Prevention and Treatment of Atherosclerosis. Eilat, 2013. December 2013, Royal Beach Poster
42. Charach G.
Statin treatment and Outcome in Patients with Severe Heart Failure.
18th Annual Congress of Society for Research and Prevention of Atherosclerosis.
Eilat 24-27 of December 2013, Royal Beach Poster
43. Charach G.
Suprapatellar Pouch Perforation due to Femoral Abscess.
6th International Congress of Slovac Society for Arthroscopic Surgery and Sport Traumatology. Slovakia, 2013. Case presentation
44. Charach G.
Diabetes and Pain Categories Debates.
Israel Family Physician Association. Dead Sea, 12-14 of December 2013.
45. Charach G.
The Diabetes Treatment Issue.
Israel Family Physician Association Meeting. Dead Sea 2013.
46. Charach G.
Insulin and GLP-1 combined treatment
Insulin Club. Berlin.Germany Royal Hall 12.12.2013
47. Charach G.
GLP-1 and Lantus Combination.
Diabetes. LILIOT Hall 24.12.2013 Panel
48. Charach G.
AHA/ ACC Recommendations to Hypercholesterolemia treatment.
Tel Hashomer Meeting 28 of February 2014.
49. Charach G.
RCC and Diabetees Incipidus short Communications
27th Annual European Association for Cancer Education. Caen, France. 26-28 of March 2014.
50. Charach G.
Unusual presentation of Cryptococcal meningitis. Short 3minutes presentation
European and Pan-Russian Conference on Mycology (KASHKINs LECTURES. St. Petersburg 9-11 July 2014.
51. Charach G.
Cardiology. Trans Catheter Therapy.
GI. Global Summit on Innovations in Interventions. 2014–05–12 Sao Paulo Brazil.
52. Charach G.
Round Table Discussion
2nd Global Cardiovascular Forum St. Petersburg. European Society of Cardiology Moscovskie Vorota 4-6 June 2014.
53. Charach G.
Insulin Club-Participation in Debates.
Insulin Club
Berlin-November1-3 2014.
54. Charach G.
TECOS CV Safety Trial & Evolving Role of Treatment for Patients With T2DM and CV Disease.
ECS London Sunday 30 August 2015 Debates
55. Charach G.
Antibodies to Oxidized LDL As Predictors of Morbidity and Prognosis in Heart Failure Patients Failure Patients ≥65.
International Audio –Video Slides Conference. 2015.
56. Charach G.
Human Being in Crisis-Mental Norma and Pathology. Ritalin
Human International Conference on Forensic Psychiatry. October 2015, Klaipeda, Lithuania.
57. Charach G.
Ritalin impact on dyslipidemia
Mental Health 2015. Kalipeda, Lithuania.
Oral Presentation
58. Charach G.
Antibodies to Oxidized LDL.
Redox. Paris June 23 2015
59. Charach G.
Oxidative Stress Reduction, Redox Homeostasis & Antioxidants
International Society of Antioxidants Meeting. Paris June 22-24, 2015 Oral presentation.
60. Charach G.
Antibodies to Oxidized LDL are Useful Predictors of Morbidity and Prognosis in Heart Failure Patients in Elderly.
BIT’s 8th Annual International Congress of Cardiology (ICC-2016) May 28-30, 2016 Barcelona.
61. Charach G.
Cannabiod hyperemesis treatment.
"Meir" Congress. Kfar Saba, 6-10 November 2018.
62. Charach G.
Strong Correlation Of Stroke And Mortality With Low Bile Acid Output.
87th EAS Congress, Sweden. 26–29th May 2019.
63. Charach G.
Impaired Brownian movement of erhytrocites in hyperinflamation.
Meir" Congress. Kfar Saba, 1-10 November 2020.
D.3. ABSTRACTS
1. Halpern Z, Rubin M, Charach G, Dvir A, Gilat T.
Infusion of lipid emulsions does not alter the fatty acid distribution in the bile.
Clinical Nutrition, Abstract 9, 39-40, 1990. No IF
2. Charach G.
Decreased bile acid output in patient with coronary atherosclerosis.
Israeli society for research, prevention and treatment of atherosclerosis.
Isr.J.Med.Sc. 1996 . Supl 1. Abstract. IF-was 0.5
3. Charach G, Rabinovich P, Konikoff F.
Fecal bile acid excretion in patients with coronary atherosclerosis and in mached controls.
Atherosclerosis 1997; 1349(1,2):28-29. Abstract IF-4.6
4. Charach G, Rabinovich P.
Monitoring of Acute Pulmonary Edema by Internal Thoracic Impedance.
Canad. J.Cardiol.13,supl - B: 258, 1997 Abstract
5. Charach G, Rabinovch P, Groskopf I, Weintraub M.
Low fecal bile acid output in patients with coronary artery disease(CAD).
4th International symposium on Multiple Risk Factors in Cardiovascular Disease: strategies of prevention of coronary heart disease, cardiac failure and stroke.
Amer J Med 1997 ( Supl- 6; 55-66) Abstract IF-5.17
6. Groskopf I, Charach G, Ringel Y, Weintraub M.
Clearance of chylomycrone remnants in normolipidemic postmenopausal women is enhanced by estrogen treatment.
4th International Symposium on Multiple Risk Factors in Cardiovascular disese: strategies of prevention of coronary heart disease, cardiac failure, and stroke.
Amer J Med 1997(Supl- 6: 82-83) Abstract IF-5.17
7. Weintraub M, Groskopf I, Charach G.
Significant fluctuations in plasma lipids and lipoproteins of hyperlipidemic postmenopausal women on cobineld hormone replacement therapy.
Canad. J.Cardiol.13,supl - B: 250, 1997 Abstract
8. Charach G, Rabinovich P, Weintraub M.
Detecting Pulmonary Edema at Pre-Clinical Stage and Monitoring its Course.
Journal of the Israeli Heart Society1998 (Supl-46)IF-was 0.5 Abstract
9. Charach G, Shochat M, Rabinovich P I, Weintraub M.
Monitoring of Acute Pulmonary Edema.
6th International conference on non invasive cardiology. Jerusalem, Israel, December 20-22 1998.
Isr J Med Sci( Supl-34) IF-was 0.5
10. Groskopf I, Charach G, Weintraub M.
Chylomicrone Remnants is Dependent on The Ratio of Total to HDL-C in Normolipidemic Individuals with Normal Coronary Arteries.
Athrosclerosis 1999 (Supl 6, 16-17) Abstract IF-4.6
11. Charach G, Rogowsky O, Weksler D, Sheps D, Keren G, George J.
Total lymphocyte count as predictor of outcome in patients with chronic heart failure Cardiology Update.
12. Charach G, Kazatsker A, Rabinovich P, Shochat M, Frimerman A, Weintraub M, Shotan A, Maisel S.
Internal Thoracic Impedance monitoring :a new tool for the early diagnosis and treatment of acute heart failure.
Eur J Heart Fail.2005,Supl(4):79-80.
13. Charach G, Michowitz Y MD, Rubinstein A, Wexler D, Sheps D, Keren G, George J.
Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic
heart failure .Cardiology Update 2007 Abstract
14. Charach G, Roth A, Wexler A, Sheps D, Keren G, George J.
Baseline LDL- Cholesterol Levels and Outcome in Patients with Heart Failure.
Atherosclerosis 2008(Supl 9), 1:86.Abstract IF-4.6
15. Charach G, Rogowsky O, Weksler D, Sheps D, Keren G, George J.
Low LDL- Cholesterol Levels and Outcome in HF Patients.
Cardiology Update 2009 Abstract
16. Charach G.
Femoral Abscess due to Suprapatellar Pouch Perforation.
(Case Report Electronic Journal).
Surgy Tec 2009, June 5.
17. Charach G, Rogowsky O,Weksler D, Sheps D, Keren G, George J.
Total lymphocyte count as predictor of outcome in patients with chronic heart failure.
Cardiology Update 2010
18. Charach G, Geiger K.
Diminished excretion of cholesterol in the Bile Acid Excretion - Risk Factor for Coronary Artery Disease.
85th EAS Congress 24-26 April 2017. Prague
Atherosclerosis – SAG123, Abstract 263/2017 e74 Honorarium
19. Charach L, Charach G.
Strong Correlation Of Stroke And Mortality With Low Bile Acid Output
87th EAS Congress, Sweden. 26–29th May 2019
Atherosclerosis 2019 Abstract EAS 2019 Volume187 e275–e276. 2019
E. ITEMS IN ENCYCLOPEDIAS
F. BOOKS EDITED
G. OTHER PUBLICATIONS (Encyclopedias; Reports; Letter to Editors)
1. Halpern Z, Rubin M, Charach G, Dvir A, Gilat T.
Infusion of lipid emulsions does not alter the fatty acid distribution in the bile.
Clinical Nutrition, 9, 39-40, 1990. IF-3.731
2. Charach G, Rabinovich P, Konikoff F.
Fecal bile acid excretion in patients with coronary 11th international Symposium on
Atherosclerosis.
Atherosclerosis. 1997;134(1-2):1-419, P1.59
3. Weintraub M, Charach G, Grosscoph I.
Diet therapy in dyslipidemia.
Cardiology Update 1995; 11: 12-16 No IF
4. Charach G, Rabinovich P, Konikoff F.
Fecal bile acid excretion in patients with coronary atherosclerosis and in mached controls.
International Journal for research and investigation on Atherosclerosis and related diseases. 1997;134(1-2):1-419, P1.59
5. Charach G, Grosscopf I, Weintraub M.
Significant fluctuation in plasma and lipoproteins of hyperlipidemic postmenopausal women on combined hormone replacement therapy.
Canadian Journal of Cardiology1997 13, Suppl B 250 IF-3.358
6. Charach G, Rabinovich P.
Monitoring of Acute Pulmonary Edema by Internal Thoracic Impedance.
Canadian Journal of Cardiology1997 13, Suppl B 198 IF 3.358
7. Charach G, Rabinovich P, Weintraub M.
Detecting pulmonary edema at preclinical Stage and monitoring its course.
Journal of the Israel Heart Society Suppl.1998 ;1:46-47 No IF
8. Shochat M, Charach G, Kazatzker M, Mosseri M, FriemermanA, Rabinovich P, Shotan A, Meisel S.
Internal thoracic impedance monitoring: a new tool for the early diagnosis and treatment of acute heart failure.
European Journal of Heart Failure. Suppl; 2006; 4 (1), 86, P-282 IF-4.896
9. Charach G.
Bezafibrates cause moderate,reversible impairment in renal functionin patients without prior renal disease.
Atherosclerosis 2005 Suppl 2 87-88 P-123 IF-4.6
10. Weintraub M, Charach G, Grosscopf I.
Diet in Dyslipidemia.
Cardiology Update 2006; 11: 12-16: No IF
11. Charach G, Rabinovich P, Konikoff F.
Fecal bile acid excretion in patients with coronary atherosclerosis and in mached controls.
Atherosclerosis 2006 Suppl134(1-2):1-41 1.p-59 IF-4.6
12. Charach G, Michovich Y, Wexler D, Sheps D, Keren G, George J.
Antibodies to Oxidazed LDL as Predictor of Morbidity and in Patients with Heart Failure.
Journal of the Israel Heart Society 2007 Suppl 1. 23-24 P.-256
13. Charach G, Rogowsky O, Weksler D, Sheps D, Keren G, George J.
Baseline LDL- cholesterol Levels and Prognosis in Patients with Severe HF.
Journal of the Israel Heart Society 2008 Suppl 66-67 No IF
14. Charach G, Rogowsky O, Weksler D, Sheps D, Keren G, George J.
Baseline LDL- Cholesterol Levels and Outcome in Patients with Heart Failure.
Atherosclerosis (S) 2008, 9/1:86. IF-4.6
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
15. Charach G.
LDL- Cholesterol and Outcome Prediction in Patients with Congestive Heart Failure.
Journal of Cardiology & Current Research. 2014;1(2).
IF NOT INDEXED.
16. Charach G, Rubalsky O, Argov O, Geiger K, Rogowski O, Charach L, George J, Grosskopf I.
The Usefulness of Monitoring Pleural Effusion Treatment by the Internal Thoracic Impedance Method.
Journal of Cardiology & Current Research. 2015;Volume 4(Issue 2).
IF NOT INDEXED.
17. Charach G.
[Are statins useful in heart failure syndrome?]
Jokopost Medicine. https://www.jokopost.com/medecine/7491/
September 5, 2015. Accessed February 10, 2020. [Hebrew]
18. Charach G, Argov O, Nochomovich H, Geiger K, Charach L, Steinvil R, Rogowski O, Grosskopf I.
Cephalosporin-induced Neurological Toxicity in Elderly Patients with Preserved Renal Function.
Arch Med (Oviedo). 2016;8(6).
IF NOT INDEXED.
19. Charach G.
Debates: The Role of Oxidsed Stress.
G-Med. 2017 Panel in Vebiner. Opinions
20. Charach G, Friedman I, Nochomovich H, Rogowski O, Charach L, Steinvil R, Angel Y, Argov O.
Whether Atmospheric Pressure Changes Predict Variations in Blood Pressure.
Journal of Cardiology & Current Research. 2017;Volume 9(Issue 4).
IF NOT INDEXED.
21. Rabinovich A, Charach G, Rabinovich P, Lerman Y.
Enzymatic remodeling of connective tissue as a novel approach to rejuvenation in mammals.
International Journal of Geriatrics and Gerontology. 2017;1(1).
IF NOT INDEXED.
22. Rabinovich AP, Rabinovich PD, Charach G, Lerman Y.
[Controllable systemic destruction of old collagen fibers as a novel approach for rejuvenating biological aging in mammals.].
Adv Gerontol. 2019;32(3):331-7. [Russian]
IF NOT INDEXED.
